|
ZNF440 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.67049715674261E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.82190001868565E-09 |
| Normal-vs-Stage2 |
1.075930E-03 |
| Normal-vs-Stage3 |
2.24290030992336E-10 |
| Normal-vs-Stage4 |
2.60420018882712E-10 |
| Stage1-vs-Stage2 |
2.463200E-01 |
| Stage1-vs-Stage3 |
4.819800E-02 |
| Stage1-vs-Stage4 |
7.818200E-03 |
| Stage2-vs-Stage3 |
1.958460E-02 |
| Stage2-vs-Stage4 |
2.982400E-03 |
| Stage3-vs-Stage4 |
2.829000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.19926291120009E-12 |
| Normal-vs-AfricanAmerican |
1.720720E-03 |
| Normal-vs-Asian |
1.52538000000035E-05 |
| Caucasian-vs-AfricanAmerican |
3.283000E-01 |
| Caucasian-vs-Asian |
3.559800E-01 |
| AfricanAmerican-vs-Asian |
7.939600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01209999994845E-07 |
| Normal-vs-Female |
1.62909685741397E-11 |
| Male-vs-Female |
3.928400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.88320000096931E-08 |
| Normal-vs-Age(41-60Yrs) |
3.56849993998765E-10 |
| Normal-vs-Age(61-80Yrs) |
1.20359999966624E-07 |
| Normal-vs-Age(81-100Yrs) |
2.680400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.803400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.737800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.494600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.482800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.239000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.187800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.319000E-03 |
| Classical-VS-Follicular |
5.245600E-02 |
| Classical-VS-Other |
3.954000E-01 |
| Classical-VS-Normal |
8.15189999947563E-08 |
| Tall-VS-Follicular |
5.72229999999951E-05 |
| Tall-VS-Other |
4.874600E-01 |
| Tall-VS-Normal |
9.21349663229876E-11 |
| Follicular-VS-Other |
2.069400E-01 |
| Follicular-VS-Normal |
9.556200E-04 |
| Other-VS-Normal |
3.999800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.06320000049199E-07 |
| Normal-vs-N1 |
2.14590012426186E-10 |
| N0-vs-N1 |
1.299710E-03 |
|
|
